{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-006675","form_type":"8-K","ticker":"CVRX","cik":"0001235912","company_name":"CVRx, Inc.","filed_at":"2024-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.618868+00:00","generated_at":"2026-06-06T17:47:13.089336+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"CVRx Q4 revenue $11.3M (+58% YoY); CEO Nadim Yared to retire; FY23 rev $39.3M (+75%)","bullets":["Q4 revenue $11.3M (+58% YoY); US HF revenue $10.2M (+70% YoY).","FY23 revenue $39.3M (+75% YoY); net loss $41.2M ($1.99/share); cash $90.6M.","Active implanting centers 178 at year-end, up from 106 in prior year.","CEO Nadim Yared announces retirement; board to conduct succession search; Yared stays until successor appointed.","FDA approved expanded Barostim labeling; CMS increased outpatient payment to ~$45,000; market opportunity updated to $2.2B annually."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-006675","json":"https://secwatch.observer/filing/0001104659-24-006675.json","markdown":"https://secwatch.observer/filing/0001104659-24-006675.md","text":"https://secwatch.observer/filing/0001104659-24-006675.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1235912/000110465924006675/0001104659-24-006675-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1235912/000110465924006675/tm244110d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T17:47:13.089336+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a6cd63f696a52eb07819cfda811586e59af64069","claim":"CVRx, Inc. updated its the quarter and year ended December 31, 2023 guidance (reaffirmed).","evidence_excerpt":"On January 25, 2024, CVRx, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1235912/000110465924006675/0001104659-24-006675-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and year ended December 31, 2023"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}